Mr. Speaker, the Patented Medicine Prices Review Board can determine if the price is excessive. In such case, it is possible that it has the requisite authority to have the price lowered. It is a quasi-judicial board, independent from the government. I support this system.
In the House of Commons on June 13th, 2006. See this statement in context.